| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |